What Makes a Hand-Protection Business Defensible

In hand-protection and safety-distribution deals, EBITDA is where diligence starts, not where it ends. The financials tell you what the business earned. They rarely tell you whether the category position is defensible, whether the margin is durable, or whether the post-close growth plan can actually be executed in the field. Those are the things that decide whether the price you pay turns into the return you modeled.

I have spent most of my career running branded hand-protection businesses — ones that supplied private-label programs as well — across multiple channels and continents, and the pattern is consistent: the deals that disappoint often had a clean income statement and an unexamined demand story.

That gap matters more in hand protection than in most PPE categories. Gloves are application-specific, SKU-intensive, replenishment-driven, and shaped by an awkward mix of end-user preference, distributor behavior, sourcing reliability, product performance, and private-label substitution. OSHA's hand-protection standard makes the underlying point in regulatory terms: glove selection is tied to specific hazards and work conditions, not to a generic product category¹. What appears as a single "gloves" line on a P&L is really dozens of distinct application businesses, each with its own economics.

Start with the demand backdrop

Before any of the six questions below, I would pressure-test the assumption underneath most hand-protection growth stories: that the category moves as one. In my view it does not — though not in the way the gloomier forecasts assume. The major branded players are still reporting volume growth in their core businesses, so this is not a declining market. Demand is simply uneven, and where a business sits within it matters far more than the category average.

Automation is the risk most people reach for first, and it is real. The mistake is to treat it as either already finished or comfortably far off; it is neither. It is here now, but at very different levels of adoption from one plant to the next. Where it has taken hold, it has tended to remove exactly the high-injury manual work that once drove glove demand: robotic machine-tending that loads and unloads metal-stamping and power presses and keeps hands out of the die, automated part removal that takes operators away from hot injection-molding machines, and robotic CNC and material-handling cells. A great deal of handling and assembly work is still done by hand, because automation is expensive and, for many smaller shops, labor is still cheaper. But the direction is not in question: the Bureau of Labor Statistics projects overall employment in production occupations to decline over the 2024–34 decade as robotics and automated machinery absorb repetitive tasks, with double-digit projected declines in roles such as metal fabricators and machine assemblers². The point for diligence is not that gloves disappear; it is that this is a multi-year erosion already underway, and any model that projects volume several years out has to price it in rather than assume today's manual intensity holds.

So the exposure is uneven, and it concentrates in commoditized, high-volume products — the ones most automatable over time, and the most vulnerable to imports and to distributor private label. Premium, application-specific, and required-use products are far more defensible, and several segments are growing outright: critical and controlled environments, laboratory and life sciences, and healthcare, where hand protection is mandated. There are real tailwinds, too — reshoring could drive a genuine boom in hand-protection use, particularly among smaller manufacturers, and data centers consume these products as well³.

That is the point for diligence. The question is not whether the category is growing; it is whether a given business's volume sits in the defensible, growing, required-use segments or in the commoditized ones exposed to automation, imports, and private label. A plan that leans on the category rising is fragile. A plan built on share in defensible segments — where expertise, specification, and field execution still matter — is a far more credible thesis. The first thing to ask of any model is which of the two it depends on.

Why this matters now

Investor and strategic interest in PPE, safety distribution, and hand protection remains real, and the category has been actively traded. Ansell acquired Kimberly-Clark's Personal Protective Equipment business — bringing the Kimtech and KleenGuard brands — for US$640 million, completing the deal in mid-2024⁴. In 2025, Honeywell completed the sale of its PPE business to Protective Industrial Products, a portfolio company of Odyssey Investment Partners, for $1.325 billion⁵. And Bunzl completed the acquisition of Guantes Internacionales, a Mexico-based own-brand PPE distributor with a strong focus on gloves⁶. Those transactions do not prove that every hand-protection asset is attractive. They show why the specific category dynamics deserve scrutiny before a growth plan is underwritten — because in gloves, the issues that matter usually sit below the headline numbers.

With that backdrop in view, here are the six questions I pressure-test before getting comfortable with any hand-protection or safety-distribution thesis.

1. What exactly are you buying?

A glove manufacturer, a branded hand-protection company, an importer, a PPE distributor, and a safety-supply platform can all sit in the same category and create value in completely different ways. Separate them before you value them:

• Branded revenue versus private-label revenue
• Proprietary or controlled product versus distributed third-party product
• Application-specific solutions versus commodity replacement
• Industrial hand protection versus broader PPE or safety supply
• End-user-driven demand versus distributor-driven demand
• Domestic, nearshore, or offshore sourcing dependence

Two businesses with near-identical revenue and EBITDA can carry very different risk. One owns a defensible application position with genuine end-user pull. The other is reselling sourced product into channel access it does not control — a far more fragile asset than the multiple usually implies.

2. How strong is the glove category — not how big?

For distributors and industrial suppliers, gloves can be one of the most important categories in the PPE portfolio. But size is not strength. A strong glove category shows disciplined product selection, credible and redundant supplier relationships, a coherent good/better/best architecture, a sales force trained to sell application rather than price, repeatable end-user conversion, and margin logic that holds up under scrutiny. A weak one looks large on paper but is over-broad, poorly segmented, exposed to line-item price comparison, and unsupported by anyone in the field who can defend it. The question is not how much glove revenue exists. It is how well the category is actually managed.

3. Who creates demand — and who can take it away?

In hand protection, the person who specifies the product, the person who buys it, and the person who wears it are often three different people. Safety managers, purchasing teams, distributor representatives, supervisors, and the workers themselves all influence the decision. So the real question is who owns the demand.

The strongest businesses create genuine end-user pull and let it flow through the channel — they make the distributor more valuable, not less. The weakest confuse distributor stocking with demand. If a product sits on a distributor's shelf only because it was bought in, with no end-user reason to specify it, that demand can be redirected the moment the channel finds a better-margin substitute — frequently the distributor's own private label. Before you underwrite the revenue, establish whether the company creates pull-through demand or merely rents shelf space.

4. Are the margins durable, or just currently high?

Gross margin tells you the level, not the quality. High margins can rest on technical differentiation, brand strength, favorable mix, disciplined sourcing, or limited competition — or on temporary supply conditions and a sourcing advantage that resets at the next contract. Some of those survive a change of ownership; some do not. Diligence should decompose margin by product family, customer type, channel, branded-versus-private-label mix, application segment, and supplier base. The practical question is whether the margin is earned by defensible value or simply rented from conditions that may not outlast the deal.

Durability also has a forward-looking dimension a snapshot will miss. For a branded business, a premium is earned on today's product, and today's product depreciates — competitors match it, the claim becomes table stakes, imports and private label replicate it for less. Margins hold only where a living innovation engine sits behind them: sustained R&D, a real pipeline, and the commercial muscle to convert both into specified, adopted products. A company that simply sells what it already has, only better, will find that approach has a ceiling — and then a downward slope. The tell in diligence is whether you are buying an innovation engine or harvesting a static portfolio dressed up as a durable one.

Marketing is the other half of that equation, and the easiest investment to quietly cut. A premium position is not a fixed asset — it is kept alive by being seen and re-sold: to the distributors who decide what to stock and push, and to the end users who decide what to specify and ask for by name. That takes sustained spend — application messaging, field activation, training, and a constant reminder of why the product earns its price. Underfund it and the margin can look better for a year or two while the brand's voice is lost among competitors who keep investing and are genuinely good at sales and quality. The demand base erodes well before the income statement shows it. So an unusually high margin can be a warning as easily as a strength: confirm it is not being manufactured by starving the marketing and innovation that hold the position together.

5. Is private label a lever, a threat, or both?

Private label is the issue I would push hardest on. For a distributor, a well-built private-label glove program can lift margin, deepen category control, and make customers stickier. For a branded manufacturer, a distributor's private label can be the substitution threat that quietly erodes the very position you paid for.

The distinction that matters is whether the program is a real category strategy or a sourcing exercise dressed up as one. Most underperforming programs are the latter — a collection of sourced SKUs with a logo, no product architecture, no supplier-qualification discipline, no quality documentation, no sales enablement, and no credible end-user reason to choose the line over the brand it is displacing. A real program has all of those. In diligence, "we have private label" is not an answer. How it is built, defended, and sold is the answer.

6. Can the organization actually execute the plan?

Most glove and safety businesses have reasonable growth ideas. The harder question is whether the organization can run them. In my experience the product is rarely what is broken — it is the execution around the product: target-segment focus, account discipline, distributor activation, application-based sales tools, product training, and the leadership capacity to manage growth and SKU complexity at the same time. This is where diligence has to connect the investment thesis to field-level reality. A growth plan can be sound on paper and undeliverable in practice if the capabilities, the channel behavior, and the people are not there before close.

What good commercial diligence should produce

Good diligence does not stop at cataloguing risk. It should make explicit what has to be true for the thesis to work, and where post-close value can realistically be created — glove-category rationalization, private-label program redesign, supplier diversification, application-based sales enablement, margin and mix management, SKU simplification, distributor-strategy refinement, or a disciplined add-on roadmap. The goal is not a generic checklist. It is a clear separation of three things: what is a true deal risk, what is a fixable operating gap, and what is a genuine value-creation opportunity under the right ownership and leadership.

For operators, not just acquirers

These six questions are not only for someone underwriting a deal. If you run a glove or hand-protection business — a brand, a private-label program, or a distributor's category — they are the same questions that tell you whether your own position is as defensible as you believe. The most useful diligence a management team can run is on itself, before a buyer runs it for them.

The bottom line

Hand protection can be an excellent category to own. It is technical enough to support differentiation, replenishment-driven enough to compound, and complex enough to reward operators who actually manage it. That same complexity is where risk hides — behind broad PPE exposure, strong historical margins, and a large SKU base.

For anyone evaluating a glove, hand-protection, or safety-distribution asset, the questions that move the answer are practical:

• Who controls demand?
• How strong — not how big — is the glove category strategy?
• How defensible is the product position?
• How durable are the margins?
• How exposed is the business to private label and substitution?
• Can the team execute after close?

Answer those well and the multiple either makes sense or it does not. Applied Protection Advisory works with investors and operators on exactly these questions — with category-specific, operator-level diligence rather than a generic safety-market overview.